975
Participants
Start Date
August 19, 2021
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2029
MINIject™ Implant
The MINIject™ SO627 is an integrated system for Minimally Invasive Glaucoma Surgery (MIGS) comprised of a glaucoma drainage implant, the MINIject™ SO627 and the SO Delivery System, designed to deliver the MINIject™ implant into the supraciliary space.
NYU Langone Ophthalmology, New York
Eye Associates of Fort Myers, Fort Myers
Vanderbilt Eye Institute, Nashville
Apex Eye Clinical Research, LLC, Mason
Eye Centers of Racine and Kenosha, Kenosha
Minnesota Eye Consultants, Bloomington
Virdi Eye Clinic, Rock Island
Illinois Eye Center, Peoria
Stiles Eyecare Excellene and Glaucoma Institute, Overland Park
Eye Consultants PC, Omaha
LA Eye and Laser, Alexandria
Vold Vision, Fayetteville
Oklahoma Eye Surgeons, Oklahoma City
Glaucoma Associates of Texas, Dallas
Ophthalmology Associates, Fort Worth
Houston Eye Associates, Houston
Berkeley Eye Center, Houston
R and R Eye Research, San Antonio
El Paso Eye Surgeons, El Paso
Grand Junction Eye Care, Grand Junction
Intermountain Eye Center, Eagle
The Eye Institute of Utah, Salt Lake City
Arizona Advanced Eye Research Institute, Glendale
Center for Sight Las Vegas, Las Vegas
Beverly Hills Institute of Ophthalmology, Beverly Hills
Sacramento Eye Consultants, A Medical Corporation, Sacramento
Reeve Woods Eye Center, Chico
Spokane Eye Clinical Research, Spokane
Prism Eye Institute, Oakville
The Institute de l'Oeil des Laurentides, Boisbriand
Clinique Opthalmologies Bellevue, Montreal
Swiss Glaucoma Research Foundation Swiss Visio Montchoisi, Lausanne
Queen Victoria Hospital NHS Foundation Trust, East Grinstead
Glaucoma Service Moorfields Eye Hospital, London
Imperial College Healthcare NHS Trust Western Eye Hospital, London
KCL Frost Eye Research Department St Thomas' Hospital, London
Research & Development Unit, Learning and Research Centre (LaRC), York Hospital, York
Lead Sponsor
iSTAR Medical
INDUSTRY